Method and Apparatus for Modeling Atherosclerosis
    1.
    发明申请
    Method and Apparatus for Modeling Atherosclerosis 审中-公开
    用于建模动脉粥样硬化的方法和装置

    公开(公告)号:US20080249751A1

    公开(公告)日:2008-10-09

    申请号:US11875809

    申请日:2007-10-19

    IPC分类号: G06F17/10 G06G7/60

    CPC分类号: G16H50/50

    摘要: The invention encompasses novel computer models of atherosclerosis and systems for predicting development and progression of atherosclerosis as well as associated cardiovascular risk. In particular, the computer model of atherosclerosis comprises a) a cholesterol metabolism module; b) an atherogenesis module; and c) a plaque stability module. The computer model optionally further comprises a cardiovascular risk module.

    摘要翻译: 本发明包括动脉粥样硬化的新型计算机模型和用于预测动脉粥样硬化的发展和进展的系统以及相关的心血管风险。 特别地,动脉粥样硬化的计算机模型包括a)胆固醇代谢模块; b)动脉粥样硬化发生模块; 和c)斑块稳定性模块。 所述计算机模型还可包括心血管风险模块。

    Biomarkers For Assessing Altherosclerotic Potential
    3.
    发明申请
    Biomarkers For Assessing Altherosclerotic Potential 审中-公开
    用于评估动脉粥样硬化潜能的生物标志物

    公开(公告)号:US20100120050A1

    公开(公告)日:2010-05-13

    申请号:US12616701

    申请日:2009-11-11

    IPC分类号: C12Q1/68

    摘要: The invention also provides methods, apparatuses and reagents useful for predicting future atherosclerosis based on expression levels of genes selected from the set of 68 genes with differential expression in response to pioglitazone and rosiglitazone. The invention also discloses reagent sets and biomarkers for predicting progression of atherosclerosis induced by anti-diabetic therapy in a subject. In one particular embodiment the invention provides a method for predict whether a compound will induce atherosclerosis using gene expression data from sub-acute treatments.

    摘要翻译: 本发明还提供了可用于预测未来动脉粥样硬化的方法,装置和试剂,其基于选自具有对吡格列酮和罗格列酮的差异表达的68个基因的基因的基因的表达水平。 本发明还公开了用于预测受试者中由抗糖尿病治疗引起的动脉粥样硬化进展的试剂组和生物标志物。 在一个具体实施方案中,本发明提供了使用来自亚急性治疗的基因表达数据来预测化合物是否将诱导动脉粥样硬化的方法。

    Simulating Patient-Specific Outcomes
    4.
    发明申请
    Simulating Patient-Specific Outcomes 审中-公开
    模拟患者特异性结果

    公开(公告)号:US20090150134A1

    公开(公告)日:2009-06-11

    申请号:US12269852

    申请日:2008-11-12

    IPC分类号: G06G7/60

    CPC分类号: G16H40/20

    摘要: The invention encompasses systems, methods, and apparatus for predicting clinical outcomes and monitoring an individual's response to a therapeutic regimen. The invention further encompasses methods for predicting cardiovascular risk based a genetic marker status and methods for modifying a computer to reflect genetic data and for incorporating genetic markers into a virtual population.

    摘要翻译: 本发明包括用于预测临床结果并监测个体对治疗方案的反应的系统,方法和装置。 本发明还包括基于遗传标记状态预测心血管风险的方法和用于修改计算机以反映遗传数据并将遗传标记并入虚拟群体的方法。